医学知识库

Archived 24: National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19]

National Advisory Committee on Immunization免疫接种2021已归档文档

ASEM 文献综述

Official National Advisory Committee on Immunization document (2021) on “Archived 24: National Advisory Committee on Immunization (NACI) statement: Recommendation on the use of the Pfizer-BioNTech COVID-19 vaccine (10 mcg) in children 5 to 11 years of age [2021-11-19]”. NACI recommendations on the use of the Pfizer-BioNTech COVID-19 vaccine in children 5 to 11 years of age: Background, methods, summary of evidence, research priorities, acknowledgments, abbreviations and frequency of solicited adverse events following immunization for COVID-19 in clinical trials.

此摘要有助于您识别文档。对于临床建议,请始终查阅官方现行版本及其更新日期。

官方文档